Pratik Shah

Insider Reports History

Entity
Individual
Location
3366 N. Torrey Pines Court, Suite 220, La Jolla, CA
Signature
/s/ Kathleen Scott, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pratik Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARS Pharmaceuticals, Inc. Director Common Stock 4.82M $44.1M $9.14 Jun 13, 2024 By The Pratik Shah Living Trust dated June 15, 2011
ARS Pharmaceuticals, Inc. Director Common Stock 0 $0 $9.14 Jun 13, 2024 By Spouse of Pratik Shah, Ph.D.
Design Therapeutics, Inc. President, CEO and Chairperson, Director Stock Option (right to buy) 525K Sep 1, 2023 Direct
ARS Pharmaceuticals, Inc. Director Stock Option (right to buy) 40K Jun 20, 2024 Direct

Insider Reports Filed by Pratik Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRY ARS Pharmaceuticals, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
SPRY ARS Pharmaceuticals, Inc. Jun 13, 2024 2 $0 4 Jun 17, 2024 Director
SPRY ARS Pharmaceuticals, Inc. Jun 7, 2024 1 $0 4 Jun 7, 2024 Director, 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Jun 4, 2024 1 $0 4/A Jun 7, 2024 Director, 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Jun 4, 2024 3 $0 4 Jun 6, 2024 Director, 10%+ Owner
DSGN Design Therapeutics, Inc. Sep 1, 2023 3 $0 4 Sep 5, 2023 President, CEO and Chairperson, Director
SPRY ARS Pharmaceuticals, Inc. Jun 27, 2023 1 $0 4 Jun 28, 2023 Director, 10%+ Owner
DSGN Design Therapeutics, Inc. Feb 1, 2023 1 $0 4 Feb 3, 2023 Executive Chairperson, Director
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 2 $0 4 Nov 10, 2022 Director, 10%+ Owner
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 0 $0 3 Nov 10, 2022 Director, 10%+ Owner
DSGN Design Therapeutics, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 Executive Chairperson, Director